Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Newly Diagnosed Glioblastoma Multiforme”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04488783
What this trial is testing

Potentiation of Chemotherapy in Brain Tumors by Zinc

Who this might be right for
Newly Diagnosed Glioblastoma Who Underwent at Least Partial Resection of the Tumor Surgically
Sheba Medical Center 30
Not applicableStudy completedNCT00725010
What this trial is testing

Temozolomide in Concomitant Radiochemotherapy Followed by Sequential Temozolomide Chemotherapy - Observational Program (Study P04816)

Who this might be right for
Glioblastoma
Merck Sharp & Dohme LLC 64
Not applicableStudy completedNCT00704808
What this trial is testing

Post Marketing Surveillance: Newly Diagnosed Glioblastoma Multiforme Treated With Radiotherapy/Temozolomide and Adjuvant Temozolomide (Study P04739)

Who this might be right for
Glioblastoma
Merck Sharp & Dohme LLC 180
Large-scale testing (Phase 3)Looking for participantsNCT07195591
What this trial is testing

Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care

Who this might be right for
Glioblastoma
GT Medical Technologies, Inc. 766
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07389278
What this trial is testing

Combination ADI-PEG 20, TMZ, and RT for Treatment of Newly Diagnosed High-grade Glioma (HGG)

Who this might be right for
GlioblastomaHigh-Grade Glioma (WHO III-IV)High-grade Glioma+2 more
Sabine Mueller, MD, PhD 97
Testing effectiveness (Phase 2)Looking for participantsNCT06161974
What this trial is testing

Study of Olutasidenib and Temozolomide in HGG

Who this might be right for
High Grade GliomaAstrocytomaAstrocytoma, Grade III+16 more
Rigel Pharmaceuticals 60
Large-scale testing (Phase 3)WithdrawnNCT04105374
What this trial is testing

Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed Glioblastoma

Who this might be right for
Anaplastic AstrocytomaGlioblastomaOligodendroglioma+1 more
NRG Oncology
Not applicableStudy completedNCT00005082
What this trial is testing

Magnetic Resonance Imaging in Determining Extent of Cancer in Patients With Newly Diagnosed Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Jonsson Comprehensive Cancer Center 1
Early research (Phase 1)Active Not RecruitingNCT04477200
What this trial is testing

Mycophenolate Mofetil Combined With Radiation Therapy in Glioblastoma

Who this might be right for
Recurrent GlioblastomaRecurrent GliosarcomaRecurrent Astrocytoma, Grade IV+3 more
University of Michigan Rogel Cancer Center 68
Early research (Phase 1)Active Not RecruitingNCT04165941
What this trial is testing

Novel Gamma-Delta (γδ)T Cell Therapy for Treatment of Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Brain Tumor Adult
University of Alabama at Birmingham 22
Testing effectiveness (Phase 2)Study completedNCT01854554
What this trial is testing

Glioblastoma Multiforme (GBM) Proton vs. Intensity Modulated Radiotherapy (IMRT)

Who this might be right for
Brain Cancer
M.D. Anderson Cancer Center 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT04574856
What this trial is testing

Multiparametric MR-Guided High Dose Adaptive Radiotherapy With Concurrent Temozolomide in Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
University of Michigan Rogel Cancer Center 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT05664243
What this trial is testing

A Phase 1b / 2 Drug Resistant Immunotherapy With Activated, Gene Modified Allogeneic or Autologous γδ T Cells (DeltEx) in Combination With Maintenance Temozolomide in Subjects With Recurrent or Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
In8bio Inc. 4
Testing effectiveness (Phase 2)Study completedNCT00402116
What this trial is testing

Phase 1/2 Study of Enzastaurin in Newly Diagnosed Glioblastoma Multiforme (GBM) and Gliosarcoma (GS) Patients

Who this might be right for
GlioblastomaGlioblastoma MultiformeGliosarcoma
Eli Lilly and Company 72
Early research (Phase 1)Study completedNCT04842513
What this trial is testing

Multi Peptide Vaccination with XS15 in Addition to Standard Postoperative Radiation Therapy and Temozolomide Chemotherapy in Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma Multiforme of Brain
University Hospital Tuebingen 15
Testing effectiveness (Phase 2)WithdrawnNCT00814593
What this trial is testing

Lymphokine-Activated Killer Cells or Gliadel Wafer in Treating Patients With Newly Diagnosed Glioblastoma Multiforme That Can Be Removed by Surgery

Who this might be right for
Brain and Central Nervous System Tumors
Lisata Therapeutics, Inc.
Testing effectiveness (Phase 2)Study completedNCT02366728
What this trial is testing

DC Migration Study for Newly-Diagnosed GBM

Who this might be right for
GlioblastomaAstrocytoma, Grade IVGiant Cell Glioblastoma+1 more
Mustafa Khasraw, MBChB, MD, FRCP, FRACP 64
Very early researchStudy completedNCT01165632
What this trial is testing

Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+13 more
Mayo Clinic 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT04881032
What this trial is testing

AGuIX Nanoparticles With Radiotherapy Plus Concomitant Temozolomide in the Treatment of Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
Centre Jean Perrin 66
Testing effectiveness (Phase 2)Study completedNCT00974987
What this trial is testing

Boron Neutron Capture Therapy, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan 32
Next Page